Clin Diabetes Endocrinol
December 2024
Background: The management of diabetic foot osteomyelitis (DFO) is complex. The targeted use of adjuvant local antibiotics, in the form of biocomposite bone void filler, in DFO, can enhance patient outcomes while minimising the adverse effects associated with systemic antibiotic therapy and its shortcomings.
Methods: We reviewed a series of 105 consecutive patients who underwent surgical management for diabetic foot osteomyelitis.
Clin Diabetes Endocrinol
November 2024